- Home
- A-Z Publications
- Current Pharmaceutical Biotechnology
- Previous Issues
- Volume 13, Issue 3, 2012
Current Pharmaceutical Biotechnology - Volume 13, Issue 3, 2012
Volume 13, Issue 3, 2012
-
-
Editorial [Hot Topic: Frontiers in Ovarian Stimulation (Guest Editor: Gian Mario Tiboni)]
More LessInfertility, or the inability to conceive, is a problem affecting millions of couples around the world. In many cases, the infertility can be treated effectively only by means of assisted reproductive techniques (ART). Ovarian stimulation is a key component of ART and is directed towards the ultimate goal of obtaining an adequate number of good quality oocytes while preventing excessive ovarian response. Recent years have Read More
-
-
-
Present and Future of Recombinant Gonadotropins in Reproductive Medicine
Pharmacological ovarian stimulation has a major role in reproductive medicine and has been used in anovulatory patients and in the induction of multifollicular development required for the procedures of assisted reproductive techniques (ART). Currently, gonadotropins are the most important tools to proceed with ovarian stimulation for all purposes, including ART and anovulation disorders, like hypogonadotropic hypogonadism Read More
-
-
-
Ovarian Stimulation: Today and Tomorrow
Authors: H. M. Fatemi, C. Blockeel and P. DevroeyIn assisted reproductive technology, medications and ovarian stimulation play a crucial role. The availability of gonadotrophins and GnRH analogues has allowed the tailoring of several stimulation schemes. The two most commonly used gonadotrophin forms are urinary hMG and recombinant FSH in combination with GnRH agonists or GnRH antagonists. Cycles stimulate with recombinant FSH appear to have a higher risk of pre Read More
-
-
-
Possibilities and Limits of Ovarian Reserve Testing in ART
Markers of ovarian reserve are associated with ovarian aging as they decline with chronologic age, and hence may predict stages of reproductive aging including the menopause transition. Assessment of ovarian reserve include measurement of serum follicle stimulating hormone (FSH), anti-Müllerian hormone (AMH), and inhibin-B. Ultrasound determination of antral follicle count (AFC), ovarian vascularity and ovarian volume Read More
-
-
-
The Role of LH in Ovarian Stimulation
Authors: Elkin Munoz, Ernesto Bosch, Iria Fernandez, Susana Portela, Ginna Ortiz, Jose Remohi and Antonio PellicerLH is a glycoprotein that plays a crucial role in folliculogenesis during the natural ovarian cycles. It has the same activity and shares receptors with hCG. However the use of LH in combination with FSH in controlled ovarian stimulation remains controversial. A practical approach concerning the usefulness of LH according to the endogenous level of LH is described herein. Specific groups of patients can benefit from ovarian stimu Read More
-
-
-
Genetic Profile of SNP(s) and Ovulation Induction
Authors: D. Loutradis, Ch Theofanakis, E. Anagnostou, D. Mavrogianni and G. A. PartsinevelosObtaining an adequate number of good quality oocytes while minimizing adverse drug reactions (ADRs) and cycle cancellation rates is considered the gold standard in controlled ovarian hyperstimulation (COH) for fertility treatment. Patients who undergo IVF/ICSI cycles tend to present with different responses to exogenous gonadotrophin administration. Research has shown that the secret probably lies in the various single n Read More
-
-
-
ESR1, ESR2 and FSH Receptor Gene Polymorphisms in Combination: A Useful Genetic Tool for the Prediction of Poor Responders
Authors: E. Anagnostou, D. Mavrogianni, Ch. Theofanakis, P. Drakakis, R. Bletsa, A. Demirol, T. Gurgan, A. Antsaklis and D. LoutradisPurpose: Previous studies in humans concluded that a multigenic model including specific FSHR, ESR1 and ESR2 genotype patterns may partially explain the poor response to FSH. The aim of our study is to analyse three different loci -polymorphisms in ESR1 Pvu II, ESR2 Rsa I and Ser680Asn FSH receptor gene- in a Greek population and their involvement in stimulation outcome and pregnancy rates. Methods: Each locus was s Read More
-
-
-
Modeling Follicle Stimulating Hormone Levels in Serum for Controlled Ovarian Hyperstimulation I: Comparing Gonadotropin Products
Authors: David H. McCulloh, Priya Maseelall, Jose M. Colon and Peter G. McGovernBackground: Despite the dangers of gonadotropin administration, our understanding of serum levels of gonadotropins in our patients is poor. We created a mathematical model of gonadotropin administration in order to learn about the temporal profiles of Follicle Stimulating Hormone (FSH) levels in patients related to the doses of different gonadotropin products administered. Methods: Model parameters for each product we Read More
-
-
-
Modeling Follicle Stimulating Hormone (FSH) Levels in Serum for Controlled Ovarian Hyperstimulation II: The Underlying Mechanisms
Authors: David H. McCulloh, Jose M. Colon and Peter G. McGovernBackground: Serum levels of follicle stimulating hormone (FSH) in patients change slowly during repeated daily injections of gonadotropin, requiring several days to achieve stable values. Using a numerical (computer) model we mimicked the serum levels of FSH using two kinetic constants that describe biological phenomena: diffusion of FSH from the injection site into the blood (τin) and disappearance of FSH from the blood by Read More
-
-
-
Modeling Follicle Stimulating Hormone Levels in Serum for Controlled Ovarian Hyperstimulation III: Improved Gonadotropin Administration
Authors: David H. McCulloh, Jose M. Colon and Peter G. McGovernBackground: A numerical model with two pharmacokinetic parameters (the rate of diffusion into the blood (τin) and the rate of disappearance from the blood (τout)) mimicks the slow changes of follicle stimulating hormone (FSH) seen in serum. It is often desired to change serum FSH levels more rapidly. Since the pharmacokinetic parameters cannot be changed in patients, we used the model to investigate changing the am Read More
-
-
-
Significantly Lower Pregnancy Rates in the Presence of Progesterone Elevation in Patients Treated with GnRH Antagonists and Gonadotrophins: A Systematic Review and Meta-Analysis
Authors: E. M. Kolibianakis, C. A. Venetis, J. Bontis and B. C. TarlatzisThe current meta-analysis aimed to answer the following research question: is progesterone elevation on the day of hCG administration associated with the probability of clinical pregnancy in women undergoing ovarian stimulation for IVF using GnRH antagonists? A literature search in MEDLINE, EMBASE and CENTRAL electronic databases followed by extensive hand-searching from two independent reviewers was performed to id Read More
-
-
-
Development of Stable Lyophilized Protein Drug Products
Authors: Richard L. Remmele, Sampathkumar Krishnan and William J. CallahanFreeze drying, or lyophilization is widely used for biopharmaceuticals to improve the long term storage stability of labile molecules. This review examines general theory and practice of rational lyophilization of biopharmaceuticals. Formulation development involving the selection of appropriate excipients, their associated physical properties, and mechanism of action in achieving a stable drug product are primary co Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cpb
Journal
10
5
false
en
